PL2103608T3 - Środek do eradykacji Helicobacter pylori mający działanie hamujące na sekrecję kwasu żołądkowego - Google Patents

Środek do eradykacji Helicobacter pylori mający działanie hamujące na sekrecję kwasu żołądkowego

Info

Publication number
PL2103608T3
PL2103608T3 PL07849849T PL07849849T PL2103608T3 PL 2103608 T3 PL2103608 T3 PL 2103608T3 PL 07849849 T PL07849849 T PL 07849849T PL 07849849 T PL07849849 T PL 07849849T PL 2103608 T3 PL2103608 T3 PL 2103608T3
Authority
PL
Poland
Prior art keywords
inhibitory activity
helicobacter pylori
gastric acid
acid secretion
eradicating agent
Prior art date
Application number
PL07849849T
Other languages
English (en)
Inventor
Masaharu Ito
Masaichi Yamamoto
Original Assignee
Link Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Link Genomics Inc filed Critical Link Genomics Inc
Publication of PL2103608T3 publication Critical patent/PL2103608T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL07849849T 2006-12-18 2007-12-18 Środek do eradykacji Helicobacter pylori mający działanie hamujące na sekrecję kwasu żołądkowego PL2103608T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006340323 2006-12-18
PCT/JP2007/001419 WO2008075462A1 (ja) 2006-12-18 2007-12-18 胃酸分泌抑制作用を併せ持つヘリコバクター・ピロリ除菌剤
EP07849849A EP2103608B1 (en) 2006-12-18 2007-12-18 Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion

Publications (1)

Publication Number Publication Date
PL2103608T3 true PL2103608T3 (pl) 2013-02-28

Family

ID=39536102

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07849849T PL2103608T3 (pl) 2006-12-18 2007-12-18 Środek do eradykacji Helicobacter pylori mający działanie hamujące na sekrecję kwasu żołądkowego

Country Status (16)

Country Link
US (1) US8778975B2 (pl)
EP (1) EP2103608B1 (pl)
JP (1) JP5097126B2 (pl)
KR (1) KR101283682B1 (pl)
CN (1) CN101553480B (pl)
AU (1) AU2007335663B2 (pl)
BR (1) BRPI0720539A2 (pl)
CA (1) CA2671949C (pl)
DK (1) DK2103608T3 (pl)
ES (1) ES2390611T3 (pl)
MX (1) MX2009006638A (pl)
PL (1) PL2103608T3 (pl)
PT (1) PT2103608E (pl)
RU (1) RU2451682C2 (pl)
SI (1) SI2103608T1 (pl)
WO (1) WO2008075462A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2420500A4 (en) * 2009-04-09 2012-09-05 Arigen Pharmaceuticals Inc PYRIDINTHIODERIVATE AND PHARMACEUTICAL COMPOSITION THEREOF AND WITH ANTI-HELIDOBACTER PYLORI EFFECT
CN110003177B (zh) * 2019-05-28 2021-11-19 沈阳药科大学 含有脲基的苯并咪唑类化合物及应用
CN110003176B (zh) * 2019-05-28 2021-12-21 沈阳药科大学 含有酰胺的苯并咪唑类化合物及其应用
UY39130A (es) 2020-03-13 2021-09-30 Janssen Biotech Inc Materiales y métodos para la unión de lectina tipo ig de unión a ácido siálico
AU2021281134A1 (en) 2020-05-27 2023-02-09 Janssen Biotech, Inc. Proteins comprising CD3 antigen binding domains and uses thereof
KR20230160314A (ko) 2021-03-24 2023-11-23 얀센 바이오테크 인코포레이티드 Cd22 및 cd79b를 표적화하는 항체
US12084501B2 (en) 2021-03-24 2024-09-10 Janssen Biotech, Inc. Proteins comprising CD3 antigen binding domains and uses thereof
WO2023046322A1 (en) 2021-09-24 2023-03-30 Janssen Pharmaceutica Nv Proteins comprising cd20 binding domains, and uses thereof
CN117534657B (zh) * 2023-11-20 2024-10-15 湖北省医药工业研究院有限公司 雷贝拉唑类似物的合成方法及应用
WO2025116549A1 (ko) * 2023-11-29 2025-06-05 제일약품 주식회사 자스타프라잔 또는 이의 약제학적으로 허용되는 염을 포함하는 헬리코박터 파일로리 제균용 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL66340A (en) 1981-08-13 1986-08-31 Haessle Ab Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation
SE8300736D0 (sv) 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
JPS6150979A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
JP2694361B2 (ja) 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤
JPH0720865B2 (ja) 1989-02-10 1995-03-08 武田薬品工業株式会社 抗菌剤
JPH0348680A (ja) 1989-07-18 1991-03-01 Yoshitomi Pharmaceut Ind Ltd 抗菌剤
JP2798588B2 (ja) 1992-08-21 1998-09-17 エーザイ株式会社 抗菌剤
PL318298A1 (en) * 1994-07-20 1997-06-09 Byk Gulden Lomberg Chem Fab Thiopyridil compounds for fighting against heliobacter
ES2171116B1 (es) * 2000-04-14 2003-08-01 Esteve Quimica Sa Procedimiento para la obtencion de derivados de (((piridil sustituido)metil)tio)bencimidazol.
US20050148634A1 (en) * 2002-03-29 2005-07-07 Zeria Pharmaceutical Co., Ltd 1-N-Aminobenzimidazole derivatives

Also Published As

Publication number Publication date
US8778975B2 (en) 2014-07-15
PT2103608E (pt) 2012-09-24
CN101553480B (zh) 2013-06-05
SI2103608T1 (sl) 2012-12-31
MX2009006638A (es) 2009-07-02
WO2008075462A1 (ja) 2008-06-26
HK1131149A1 (en) 2010-01-15
AU2007335663A1 (en) 2008-06-26
JPWO2008075462A1 (ja) 2010-04-08
KR20090101890A (ko) 2009-09-29
RU2009127750A (ru) 2011-01-27
AU2007335663B2 (en) 2011-12-15
RU2451682C2 (ru) 2012-05-27
BRPI0720539A2 (pt) 2014-01-07
EP2103608A1 (en) 2009-09-23
ES2390611T3 (es) 2012-11-14
EP2103608A4 (en) 2010-12-22
DK2103608T3 (da) 2012-09-17
CN101553480A (zh) 2009-10-07
US20100173944A1 (en) 2010-07-08
KR101283682B1 (ko) 2013-07-08
CA2671949C (en) 2011-11-01
CA2671949A1 (en) 2008-06-26
EP2103608B1 (en) 2012-08-29
JP5097126B2 (ja) 2012-12-12

Similar Documents

Publication Publication Date Title
EP2103608A4 (en) IREADIQUANT AGENT <I> HELICOBACTER PYLORI, </ I> HAVING INHIBITORY ACTIVITY ON THE SECRETION OF GASTRIC ACID
IL187236A0 (en) Compositions and methods for inhibiting gastric acid secretion
EP2088891A4 (en) CONNECTOR FOR PEN
GB2438478B (en) Connector
GB2480571B (en) Stress distributing wellhead connector
EP2086383A4 (en) CAPSULE TYPE ENDOSCOPE
PL2090135T3 (pl) Procedura przenoszenia połączenia między eNode B
AU317306S (en) Mask headgear connector
GB0813961D0 (en) Swab
EP2020200A4 (en) ENDOSCOPE SYSTEM
EP2008529A4 (en) BONBON CONTAINING AN ENZYME
SI2007384T1 (sl) Orodisperzibilne domperidon tablete
GB0909928D0 (en) Connector
EP2147677A4 (en) AGENT ERADICATING THE HELICOBACTER PYLORI
ZA200709852B (en) Spiro-benzimidazoles as inhibitors of gastric acid secretion
EP1945130A4 (en) GASTRIC BAND introducer
EP2065379A4 (en) BENZIMIDAZOLE HAVING INHIBITORY ACTIVITY OF GASTRIC ACID SECRETION
GB0615586D0 (en) Cream formulations
GB0605931D0 (en) Endoscope
GB0609171D0 (en) Improved Flexible Substrate
IL237247A0 (en) Endoscope system and flexible functionality
IL237249A0 (en) Endoscope system and flexible functionality
AU308423S (en) Confectionary
AU308559S (en) Confectionary
AU308542S (en) Confectionary